为了定义儿童中耐火/耐治疗/难治便秘的定义:一个横截面,基于问卷的在线调查
Morris Gordon1, Wathsala Hathagoda2, Shaman Rajindrajith3
1University of Central Lancashire, Preston, UK Mgordon@uclan.ac.uk.
BMJ paediatrics open
|December 12, 2024
概括
为治疗耐药性便秘制定了一个共识定义. 它被定义为3个月不响应最大药疗法的便秘,强调在专业护理环境中遵守.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 临床治疗学 临床治疗学
- 医学定义 医学定义
背景情况:
- 罗马标准缺乏对耐火性儿童便秘的定义.
- 现有的严重便秘术语不一致,阻碍了诊断和治疗.
- 在治疗上限方面缺乏共识,使难以治愈便秘的定义变得复杂.
研究的目的:
- 建立对医学上不响应便秘的共识定义.
- 确定耐火性便秘的首选术语和治疗持续时间.
- 为了解决对抗标准治疗的便秘定义的模两可.
主要方法:
- 一项在线横截面研究调查了全球1079名医疗专业人员.
- 一项两阶段的研究使用了针对儿科胃肠科医生和一般儿科医生的谷歌表单问卷.
- 调查问卷的重点是定义医疗不响应的便秘,包括持续时间和治疗失败.
主要成果:
- "耐治疗便秘"是首选的术语 (47.8%).
- 建议至少持续3个月 (37.7%) 和两种药剂 (43.2%) 的最大治疗失败.
- 良好的遵从性 (91.1%) 被认为是治疗成功的关键.
结论:
- 建议的定义:"耐治疗性便秘"是对至少两种不同药类的最大剂量至少3个月没有反应的便秘.
- 这种定义需要良好的患者合规性,并且发生在二级或三级护理中.
- 这项研究为儿童便秘的一个具有挑战性的临床问题提供了明确的,基于共识的定义.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
134
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
134
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
140
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
140
Assessment of the Rectum and Anus
156
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
156
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Inflammatory Bowel Disease V: Surgical Management
118
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
118
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147


